These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32281480)

  • 1. Circulating Tumor Cells and Fibronectin 1 in the Prognosis of Nasopharyngeal Carcinoma.
    Yu Y; Lin ZX; Li HW; Luo HQ; Yang DH; Zhou HC; Jiang DX; Zhan DC; Yang L; Liang XY; Yu ZH; Chen ZH
    Technol Cancer Res Treat; 2020; 19():1533033820909911. PubMed ID: 32281480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Significance of Excision Repair Cross-Complementation Group 1 on Circulating Tumor Cells for Nasopharyngeal Carcinoma.
    Liu T; Li Y; Song J; Li B; Wang R; Huang T; Qin Y
    Cancer Control; 2024; 31():10732748241251562. PubMed ID: 38716503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of circulating tumor cell measurement in the peripheral blood of patients with nasopharyngeal carcinoma.
    Gao T; Mao J; Huang J; Luo F; Lin L; Lian Y; Bin S; Zhao L; Li S
    Clinics (Sao Paulo); 2023; 78():100179. PubMed ID: 36963168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating mRNA Expression of VEGF, PTEN, and SOCS1 as Potential Prognostic Predictor for Nasopharyngeal Carcinoma Progression.
    Sulistyo H; Nusa AP; Poernomo MAPD; Rahman FML; Rahmatullah R; Pangestu TA; Afifah AN; Amania RR; Huda MM; Dharmawan AB; Sutono Islamanto SJ; Mubarika S; Wardana T
    Asian Pac J Cancer Prev; 2024 Sep; 25(9):2999-3006. PubMed ID: 39342576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibronectin overexpression is associated with latent membrane protein 1 expression and has independent prognostic value for nasopharyngeal carcinoma.
    Ma LJ; Lee SW; Lin LC; Chen TJ; Chang IW; Hsu HP; Chang KY; Huang HY; Li CF
    Tumour Biol; 2014 Feb; 35(2):1703-12. PubMed ID: 24081675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of circulating tumor cells and Epstein-Barr virus DNA to progression-free survival and overall survival in metastatic nasopharyngeal carcinoma patients.
    You R; Liu YP; Lin M; Huang PY; Tang LQ; Zhang YN; Pan Y; Liu WL; Guo WB; Zou X; Zhao KM; Kang T; Liu LZ; Lin AH; Hong MH; Mai HQ; Zeng MS; Chen MY
    Int J Cancer; 2019 Nov; 145(10):2873-2883. PubMed ID: 31044420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating tumor cells: a valuable indicator for locally advanced nasopharyngeal carcinoma.
    Liu T; Liu J; Wang G; Chen C; He L; Wang R; Ouyang C
    Eur Arch Otorhinolaryngol; 2024 Sep; 281(9):4963-4972. PubMed ID: 38733533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High SRC-1 and Twist1 expression predicts poor prognosis and promotes migration and invasion by inducing epithelial-mesenchymal transition in human nasopharyngeal carcinoma.
    Zhou J; Zhang J; Xu M; Ke Z; Zhang W; Mai J
    PLoS One; 2019; 14(4):e0215299. PubMed ID: 30973923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution and clinical significance of circulating tumor cells in nasopharyngeal carcinoma.
    Si Y; Lan G; Deng Z; Wang Y; Lu Y; Qin Y; Huang B; Yang Y; Weng J; Han X; Zhang B; Qin Y; Xiong W; Li B; Wu S
    Jpn J Clin Oncol; 2016 Jul; 46(7):622-30. PubMed ID: 27162320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating tumor cells with karyotyping as a novel biomarker for diagnosis and treatment of nasopharyngeal carcinoma.
    Zhang J; Shi H; Jiang T; Liu Z; Lin PP; Chen N
    BMC Cancer; 2018 Nov; 18(1):1133. PubMed ID: 30454007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA Gene Signature for Predicting Mechanisms in Nasopharyngeal Carcinoma: A Case Study on the Potential Application of Circulating Biomarkers.
    Wardana T; Oktriani R; Murjayanto CH; Putri DU; Anwar SL; Aryandono T; Haryana SM
    Microrna; 2023; 12(1):29-44. PubMed ID: 36121076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of serial analysis of circulating tumour cells for detection of minimal residual disease of metastatic nasopharyngeal carcinoma.
    Ko JM; Vardhanabhuti V; Ng WT; Lam KO; Ngan RK; Kwong DL; Lee VH; Lui YH; Yau CC; Kwan CK; Li WS; Yau S; Guo C; Choi SSA; Lei LC; Chan KC; Lam CC; Chan CK; Dai W; Khong PL; Lung ML
    Br J Cancer; 2020 Jul; 123(1):114-125. PubMed ID: 32372027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating Epstein-Barr virus microRNAs BART7-3p and BART13-3p as novel biomarkers in nasopharyngeal carcinoma.
    Lu T; Guo Q; Lin K; Chen H; Chen Y; Xu Y; Lin C; Su Y; Chen Y; Chen M; Zheng Y; Ye Y; Lin S; Zong J; Pan J
    Cancer Sci; 2020 May; 111(5):1711-1723. PubMed ID: 32155300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of LMP2A, E-Cadherin and fibronectin in nasopharyngeal carcinoma and its clinical significance].
    Zhao L; Rao J; Luo B; Chen X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Jan; 29(2):132-6. PubMed ID: 25989660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Joint quantitative measurement of hTERT mRNA in both peripheral blood and circulating tumor cells of patients with nasopharyngeal carcinoma and its clinical significance.
    Fu X; Shen C; Wang H; Chen F; Li G; Wen Z
    BMC Cancer; 2017 Jul; 17(1):479. PubMed ID: 28693532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of COX-2 expression on circulating tumor cells in nasopharyngeal carcinoma: A prospective analysis.
    Li YJ; Luo Y; Xie XQ; Li P; Wang F
    Radiother Oncol; 2018 Nov; 129(2):396-402. PubMed ID: 30082142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix Metalloproteinase 14 Overexpression Is Correlated with the Progression and Poor Prognosis of Nasopharyngeal Carcinoma.
    Yan TH; Lin ZH; Jiang JH; Lu SW; Que HX; Chen MA; He XS; Que GB; Xiao JN; Chen YQ
    Arch Med Res; 2015 Apr; 46(3):186-92. PubMed ID: 25829357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of chromosome 14 open reading frame 166 correlates with disease progression and poorer prognosis in human NPC.
    Yang L; Li F; Lei F; Wang Y; Wu S; Song L; Chen Y
    Tumour Biol; 2015 Sep; 36(10):7977-86. PubMed ID: 25964093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic values of the integrated model incorporating the volume of metastatic regional cervical lymph node and pretreatment serum Epstein-Barr virus DNA copy number in predicting distant metastasis in patients with N1 nasopharyngeal carcinoma.
    Yao JJ; Zhou GQ; Wang YQ; Wang SY; Zhang WJ; Jin YN; Zhang F; Li L; Liu LZ; Cheng ZB; Ma J; Qi ZY; Sun Y
    Chin J Cancer; 2017 Dec; 36(1):98. PubMed ID: 29284539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum LINC00339 is a promising biomarker for prognosis prediction of nasopharyngeal carcinoma.
    Qi X; Yuan L; Wu Z; Tian Y
    Int J Biol Markers; 2024 Sep; 39(3):193-200. PubMed ID: 38711286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.